Pavan Cheruvu
@PavanCheruvuMD
Followers
286
Following
260
Media
11
Statuses
170
CEO @ Bitterroot Bio, cardiologist, husband and dad
San Francisco Bay Area
Joined March 2013
RT @NickLeeper78: They say it’s about the journey, not the destination, and I couldn’t imagine a more talented and dedicated team to be on….
0
5
0
RT @rtnarch: Starlink Mini is one of the coolest inventions ever. Everyone should have, with a solar battery for emergencies. It goes whe….
0
1
0
RT @BitterrootBio: On Global Running Day, we showed our unsinkable spirit! Every mile we ran turned into a donation to the American Heart A….
0
1
0
RT @BitterrootBio: Today, we presented foundational data from our Phase 1 study of BRB-002, a novel protein therapy in development for the….
0
1
0
RT @NickLeeper78: Thanks for the invitation to present Joe. Excited to give this talk on the intersection between cancer and cardiovascular….
0
3
0
RT @LifeSciVC: Its a long journey to deliver novel classes of drugs. And new medicine "innovation cycles" always go through waves of initi….
0
14
0
And a phenomenal leadership team.
OK I promised a tweet storm on my largest positon so here goes.$RCKT is developing gene therapy for rare cardiac diseases .The lead drug is for Danon which is a mutation of the Lamp2 gene which causes a build of vacuoles in the heart and is fatal by age 30.
0
0
1
Onwards! With positive data from Phase 1, our team is now focused on initiating a Phase 2 PoC study in patients with atherosclerosis. We're one step closer to our goal of improving the lives of patients with heart disease.
Bitterroot Bio Reports Data on Safety and Target Engagement from Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers. Read the full Press Release here:
0
1
1
RT @BitterrootBio: Bitterroot Bio Reports Data on Safety and Target Engagement from Phase 1 First-in-Human Study of BRB-002 in Healthy Volu….
0
2
0
RT @davidycli: My prior post below re China x US biotech has caught the attention of a few of you . Why am I well positioned to comment on….
0
94
0
RT @BitterrootBio: Thank you for the dedication of our talented Team and Partners. We look forward to a joyful season and a 2025 filled wit….
0
1
0
RT @daphnezohar: Congrats to Neil Kumar and the $BBIO team. I have a close family member with ATTR cardiomyopathy and I’m grateful that the….
0
10
0
RT @pnatarajanmd: CLEAR: Among 7062 with MI followed for ~3y, colchicine v placebo did not improve risk for major CV outcomes but there wer….
0
15
0
RT @HeartBobH: Hypertension is one of the globe’s major public health problems substantially contributing to increases in heart disease and….
0
12
0
RT @BitterrootBio: Enrollment is complete for our Phase 1 study of BRB-002 in healthy volunteers. Topline findings are expected in early 20….
0
2
0
Enjoyed sharing my reflections with Rahul Chaturvedi on the #Biotech2050 podcast. We talked about my journey through engineering and medicine that led me to Bitterroot Bio, and the future of innovation in cardiovascular drug discovery and development. Link here:
1
0
1
RT @BitterrootBio: Join us in welcoming Georgette Verdin as our new Chief People Officer and Sherwin Chen as our new Chief Legal Officer an….
0
1
0
RT @ElizabethGore: It is un-American to deny a private company from giving grants to small business owners. These grants are critical…if th….
0
51
0